| Bioactivity | MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) inhibitor. MJ33 blocks the calcium-independent phospholipase A2 (iPLA2) activity of Prdx6[1]. |
| Name | MJ33 lithium salt |
| CAS | 1007476-63-2 |
| Formula | C22H43F3LiO6P |
| Molar Mass | 498.48 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Fisher AB, Dodia C, Chander A, Jain M. A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung. Biochem J. 1992 Dec 1;288 ( Pt 2)(Pt 2):407-11. |
MJ33 lithium salt
CAS: 1007476-63-2 F: C22H43F3LiO6P W: 498.48
MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) inhibitor. MJ33 blocks th
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.